[Federal Register: April 16, 2001 (Volume 66, Number 73)]
[Notices]
[Page 19507]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16ap01-70]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Epidemiology Research Needs Related to the Radiofrequency Energy
From Wireless Phones
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
meeting to discuss the health effects of radio frequency (RF) emissions
from wireless phones. Currently, the scientific literature relating to
the health effects of low level exposure to RF does not demonstrate the
existence of any health risk from wireless phones. National and
international scientific experts will discuss the need for research
into the incidence, distribution, and control of any adverse effects
related to RF energy from wireless phones. This meeting is being
convened as part of the Cooperative Research and Development Agreement
(CRADA) between FDA's Center for Devices and Radiological Health and
the Cellular Telecommunications Industry Association (CTIA). This is
the second meeting on this subject. FDA announced the first meeting on
April 18 and 19, 2001 in the Federal Register of March 27, 2001.
Date and Time: The meeting will be held on May 2, 2001, 8:30 a.m.
to 5 p.m. and on May 3, 2001, 8:30 a.m. to 5 p.m.
Location: The meeting will be held at the Marriott Kingsgate
Conference Center, University of Cincinnati, Cincinnati, OH 45219.
Contact: Russell D. Owen, Center for Devices and Radiological
Health, Food and Drug Administration (HFZ-114), 12709 Twinbrook Pkwy.,
Rockville, MD 20857, 301-443-7118, FAX 301-594-6775. Further
information about the CRADA is available on the Internet at http://
www.fda.gov/cdrh/ocd/wlessphonecrada.html.
Agenda: On May 2, 2001, the scientific experts will review
completed and ongoing epidemiology studies and discuss scientific
questions that have been raised by this research. On May 3, 2001, the
scientific experts will discuss specific studies that could address
these scientific questions.
Procedure: Interested persons may present scientific information
relevant to items on the agenda. Written submissions may be made to the
contact person by April 23, 2001. Oral presentations from the public
will be scheduled on May 2, 2001, between 3 p.m. and 5 p.m. Time
allotted for each presentation may be limited. Those desiring to make
formal oral presentations should notify the contact person before April
23, 2001, and submit a brief statement of the general nature of the
information they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Transcripts: Transcripts of the meeting may be requested in writing
from the Freedom of Information Office (HFI-35), Food and Drug
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857,
approximately 15 working days after the meeting at a cost of 10 cents
per page.
If you need special accommodations due to a disability, please
contact Abiy B. Desta, 301-443-7192 at least 7 days in advance.
Dated: April 11, 2001.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 01-9403 Filed 4-12-01; 9:55 am]
BILLING CODE 4160-01-S